MUFG, Mizuho, and SMFG would be the first Japanese institutions added to Anthropic’s restricted Project Glasswing rollout, a source familiar with the matter told Reuters Japan’s three megabanks are set to gain access to Claude Mythos, Anthropic’s vulnerability-hunting AI model, within roughly two weeks, a source familiar with the matter told Reuters on Tuesday. It […]

Digital transformation minister Óscar López says ‘the profit of four tech companies cannot come at the expense of the rights of millions’ as Madrid’s regulatory package moves through parliament. Spain’s digital transformation minister, Óscar López, said on Wednesday that Madrid would press ahead with a slate of rules targeting social media platforms and high-risk artificial […]

Flyers framing the Model Capability Initiative as an ‘Employee Data Extraction Factory’ appeared in US offices on Tuesday, with a petition and a UK unionisation drive in train By Tuesday afternoon, the flyers were everywhere. Meta employees at several US offices walked into meeting rooms, broke for coffee at vending machines, and used the restrooms […]

A round at the proposed terms would push the Claude maker past OpenAI on paper, less than three months after its last record-setting raise. Anthropic is in early talks to raise at least $30bn in a new financing round at a pre-money valuation above $900bn, Bloomberg reported on Tuesday, citing people familiar with the matter. […]

Gyver, a Brescia, Italy-based startup building the workforce infrastructure for Europe’s new industrial era, has today announced a €1.4 million pre-Seed funding round to strengthen its technology, unlock growth and provide a better experience for both electricians and employers.

The round was led by Brighteye, with participation from āltitude, Vento Ventures, Zanichelli Venture and existing investor Antler, alongside several business angels. 

Francesco Defendi, co-founder of Gyver, commented, “We want the job of an electrician to be as cool as being a VC or famous entrepreneur. Electricians are the most important yet neglected workers category in the modern economy. They embody the combination of brain and manual craft that cannot be replaced by AI, yet they have been left behind by modern technology. The future of work in the AI age is the future of manual craft. 

“This funding allows us to build the infrastructure that will elevate this profession and ensure that the people who are the backbone of electrification have the tools they need to thrive.”

Gyver was founded during an Antler founder residency in Fall 2024 by Defendi, Leo Acciarri, and Mattia Zarrelli. The trio had previously worked together building a general contractor for solar installations on industrial SMEs, where they witnessed firsthand the critical importance of skilled labour.

The company’s mission is to become the primary source of the electrician workforce for its customers, helping electrical employers hire, manage and empower the workers who are the essence of their business. It claims to be building the “Workforce Infrastructure for Europe’s new Industrial Era” and aims to empower the workers who will never be replaced by AI.

According to the company, while projects such as renewable energy, data centres, and grid updates are essential for the EU’s reindustrialisation, electrical contractors are facing a massive talent crisis. There are currently 28 million skilled blue-collar workers across the EU, yet an estimated 5.8 million additional workers will be required by 2030.

The startup claims to be tackling the skilled blue-collar workforce shortage. It has developed an AI-powered conversational job platform that replicates how electricians find jobs (referrals/word of mouth) and allows employers access to top talent. Over the next few years, the product will expand towards upskilling, learning and workforce productivity tools for electricians. 

Gyver aims to make the manual craft 10x more productive, similar to how software transformed white-collar desk work, and plans to do so by providing modern tools for technical skills like electrical design and PLC. 

David Guérin, Partner at Brighteye, commented, “Europe has 2.7 million electrical workers and a €3 billion hiring market that has been chronically underserved. The electrification of the world, industrial maintenance and ageing demographics are widening the gap between supply and demand faster than traditional tools can handle. 

“Gyver uses AI not to replace skilled electricians but to make each one more productive and more valuable, which is a distinction that matters. We are convinced this is the right answer to a structural problem with powerful tailwinds. We’re excited to back Francesco, Leo and Mattia: founders who know this industry from the inside and are moving with real conviction to build the category leader.”

With the new funding, the company aims to enhance Gyver’s technology, focusing on AI agents and workflows to drive growth.

The post AI for the workers it can’t replace: Italy’s Gyver raises €1.4 million to empower electricians appeared first on EU-Startups.

The Court of Justice has ruled that Italy’s AGCOM can require Meta to pay publishers for news snippets, the first time the bloc’s top court has weighed in directly. Meta lost its bid to overturn an Italian regulatory order requiring it to compensate publishers for the use of their news snippets, after the Court of […]

Europe’s external dependency exposes more than its AI sovereignty. It also affects its data sovereignty and creates political exposure. In a previous article, we discussed how Europe is heavily dependent on external providers for AI development, particularly through GPUaaS and the semiconductor industry. US companies such as Nvidia and AMD provide the GPU chips powering […]

Are you a healthtech or techbio startup looking to collaborate with pharmaceutical companies, sharpen your value proposition, and grow inside one of Europe’s strongest life sciences ecosystems? If that sounds like your company, the DayOne Accelerator could be worth a closer look.

The Basel-based programme has officially opened its new call for applications, inviting early-stage Swiss and international startups to apply for its next cohort. Launched in 2018, DayOne focuses on ventures building solutions that can accelerate pharma R&D, offering a three-month hybrid accelerator, direct access to industry experts, and tailored support without taking equity or charging fees.

What’s it about?

DayOne describes itself as a leading launchpad for startups transforming pharma R&D. Based in Basel, Switzerland, the accelerator is designed to help founders move faster by connecting them with leading life science companies, research institutions, mentors, and investors.

The programme runs over three months in a hybrid format and is built specifically for startups developing solutions for areas such as drug discovery, clinical development and clinical trials optimisation.

This can include solutions such as biomarkers or companion diagnostics, data layers that improve data flows across R&D, organ-on-chip systems, organoids, non-animal methods, lab automation, and AI tools that improve clinical trials through patient engagement, remote monitoring, patient-reported outcomes, or real-world evidence. It also includes discovery tools that provide a technology platform, rather than startups building and licensing their own asset pipeline.

The aim is not just to offer short-term momentum, but to help founders build validated partnerships, improve investor readiness, and create a clearer growth path.

Who’s it for?

The programme is aimed at early-stage healthtech and techbio startups, from pre-incorporation to Series A, that have raised less than $10 million in dilutive funding.

More specifically, DayOne is looking for ventures developing high-potential products that can transform pharma R&D and that are interested in collaborating or partnering with pharmaceutical companies.

Selected startups receive one-to-one mentorship to refine their pharma-specific value proposition, along with access to pharma experts and Basel’s wider life sciences network. The programme is equity-free and fee-free, which means founders can take part without giving up ownership or paying programme costs.

For the most promising startups in the cohort, there is also the possibility of continuing with DayOne NEXT, a longer-term support programme designed to help selected companies build, scale, and anchor their R&D in the Basel Area.

Key information

Applications for the 2026 DayOne Accelerator are open until 31 May 2026.

Here are the main dates for the upcoming cohort:

• 31 March to 31 May 2026: call for applications open
• 25 to 26 June 2026: selection days, during which 15 startups will be chosen
• 7 to 8 September 2026 in Basel: kickoff bootcamp with presentations, workshops, and networking
• Early December 2026 in Basel: innovation showcase

Beyond the accelerator itself, DayOne also offers post-programme support through DayOne NEXT. This can include up to CHF 50K in cash grant funding, up to CHF 50K in tailored services, and 12 months of office space at Switzerland Innovation Park Basel Area. The programme may also include relocation support, access to the Basel Incentive Programme, and long-term support from mentors, industry experts, and investors.

Success stories

Since its launch in 2018, DayOne says it has supported more than 128 ventures, including over 60 healthtech startups, through its pharma R&D-focused programmes.

Among the startups that have already been part of the DayOne Accelerator are InSilicoTrials, Risklick and TrialHub (cohort 2023/24); Oncoustics and Theremia (cohort 2024/25); and Lemna Bio (cohort 2025).

In 2025 alone, DayOne hosted 17 events with more than 3,500 participants across networking and thought-leadership formats, helping strengthen its position in Basel’s life sciences landscape.

For early-stage ventures developing solutions for pharma R&D, the programme offers more than mentorship and visibility. It opens the door to one of Europe’s most established life sciences hubs, with focused support designed to help startups turn promising technology into scalable business opportunities.

If you wish to take your healthtech startup to the next level, click here to apply. Remember, you have until 31 May 2026.

The post The 2026 DayOne Accelerator applications are now open: Calling Healthtech & TechBio founders! (Sponsored) appeared first on EU-Startups.

The Grand Chamber of the CJEU heard ByteDance’s appeal in Case C-627/24 P on Tuesday, the first DMA gatekeeper challenge to reach the bloc’s highest court. ByteDance’s TikTok went before the Grand Chamber of the Court of Justice of the European Union on Tuesday in a last attempt to escape its designation as a “gatekeeper” […]

DesignVerse, a Bucharest-based enterprise software startup helping modernise aviation infrastructure across Europe, has raised more than €4.6 million ($5.5 million) in Seed funding. 

Investors in this round include Begin Capital, Gapminder VC, Underline Ventures, and strategic individual angel investments from companies like Adobe, LSEG, UiPath, and more.

Andrei Manolache, CEO of DesignVerse, said, “Large organisations still lose enormous amounts of time translating design work into production software. Designers create intent, but engineers must manually reinterpret and rebuild it, which leads to inconsistency and delays.

“DesignVerse removes that friction entirely, allowing teams to generate functional enterprise applications directly from their design systems, validating the behaviour instantly with business stakeholders and bridging the gap between.”

Founded in 2024 by Andrei Manolache and Robert Dragutoiu, DesignVerse is an AI-based platform that builds and delivers complex enterprise software using an organisation’s own documentation and internal rules. It ensures that every system is built consistently across teams.

The company claims that its software integrates directly with the design systems, architecture patterns, and business logic enterprise which the client’s teams rely on, eliminating drift, fragmentation, and repeated implementation effort. “The DesignVerse platform bridges the gap between design and development by creating a context layer, unique for each large-scale organisation, enabling teams to build and modernise complex software far faster than traditional workflows,” says the company. 

Using AI, DesignVerse states that its technology allows teams to modernise operational software far faster than traditional development processes. The platform grounds its AI models in each customer’s design systems, component libraries and technical documentation. This enables software to be generated in line with the company’s existing or target architecture, as well as existing or target front-end or back-end technologies.

It is designed for organisations running complex legacy systems, including banks, cybersecurity platforms, and government infrastructure. 

It has already been adopted by a range of mission-critical organisations, including EUROCONTROL, which is responsible for coordinating air traffic across Europe. DesignVerse upgraded and modernised EUROCONTROL’S legacy software, overhauling a 15-year-old application in just over a month, compared with the estimated six months it would have taken using conventional methods, it states. 

In a statement, EUROCONTROL pointed out, “Aviation is an industry where the innovation cycle is generally slower compared to others. At EUROCONTROL, we have embarked on our largest digital transformation programme to date – the Integrated Network Management (iNM) programme – aimed at reshaping this paradigm by transforming not only our technologies but also aligning our culture with new ways of working, in collaboration with our partners.

“DesignVerse, through its AI platform, has supported us in modernising our software systems at an accelerated pace, without compromising the reliability, safety and security that remain the highest priority for our sector. We value such partnerships that contribute to our efforts to drive innovation and leverage AI at scale across the European aviation ecosystem, and ultimately improve the quality of air travel for the entire community.”

It reported that in less than five months, the company has exceeded nearly €930k ($1.1 million) in annual recurring revenue, driven entirely by enterprise customers from highly sensitive sectors.

Robert Dragutoiu, CTO and architect of the AI model pipeline behind DesignVerse, said, “Many AI coding tools available today are designed primarily for experimentation or rapid prototyping.

“Enterprises operate complex infrastructure and legacy systems, often in mission-critical environments. Software generated by AI must integrate with existing architectures and run safely in production. Our models are designed specifically for those constraints.

“Our technology builds a system-level context layer from each customer’s design systems, component libraries, and technical documentation, enabling software to be produced seamlessly in alignment with existing architecture and engineering standards, without months of custom integrations.”

With the fresh funding,  DesignVerse plans to expand its engineering team and accelerate growth across the enterprise sector, both in Europe and the US. Prior to this round, DesignVerse raised €725.3k ($850k) in pre-Seed funding, which enabled the team to build its core platform and begin working with early enterprise design partners.

The post Bucharest’s DesignVerse raises over €4.6 million Seed funding after supporting EUROCONTROL software upgrade appeared first on EU-Startups.

The Milan- and Chicago-based startup, backed by Azimut Libera Impresa’s IXC3 fund, plans to scale agentic AI for SMBs and pursue acquisitions in the US. Webidoo, an Italian-American AI company building software for small and medium-sized businesses, has closed a $25m funding round led by the IXC3 fund managed by Azimut Libera Impresa SGR. The […]

Gyver, the Italian startup developing workforce infrastructure for Europe’s industrial and energy sectors, has raised €1.4 million in pre-seed funding. The round was led by Brighteye, with participation from āltitude, Vento Ventures, Zanichelli Venture and existing investor Antler, alongside several business angels.

Founded by Francesco Defendi, Leo Acciarri and Mattia Zarrelli, Gyver is focused on addressing the growing shortage of skilled blue-collar workers across Europe, particularly in sectors linked to electrification, energy and industrial infrastructure.

As Europe accelerates investment into renewable energy, data centres and grid modernisation, demand for skilled electrical workers continues to increase. While there are currently around 28 million skilled blue-collar workers across the EU, industry estimates suggest an additional 5.8 million workers will be needed by 2030.

Gyver has developed an AI-powered conversational hiring platform designed to replicate the referral and word-of-mouth processes commonly used by electricians to find work, while helping employers identify and access skilled workers more efficiently.

The company plans to expand the platform beyond recruitment into areas including upskilling, learning and workforce productivity tools for electricians. Gyver says its long-term goal is to provide modern technical tools for tasks such as electrical design and PLC workflows, helping improve productivity across skilled trades.

Francesco Defendi, co-founder of Gyver, said:

We want the job of an electrician to be as cool as being a VC or a famous entrepreneur. Electricians are the most important yet neglected workers category in the modern economy. They embody the combination of brain and manual craft that cannot be replaced by AI, yet they have been left behind by modern technology. The future of work in the AI age is the future of manual craft.

Gyver’s broader aim is to become a workforce platform for electrical employers, supporting hiring, workforce management and worker enablement.

The new funding will be used to strengthen Gyver’s technology platform, including its AI agents and workflow systems, and to support growth while improving the experience for both electricians and employers.

Bucharest-based DesignVerse, the enterprise software startup using AI to modernise complex legacy systems, has raised more than $5.5 million in seed funding as demand grows for tools that can safely accelerate software development in mission-critical industries.

The round included investment from Begin Capital, Gapminder VC, Underline Ventures, and strategic angel investors from companies including Adobe, LSEG and UiPath. Prior to the seed round, the company raised $850,000 in pre-seed funding to build its core platform and begin working with early enterprise design partners.

Founded by former Oracle product design lead Andrei Manolache and software engineer Robert Dragutoiu, DesignVerse develops AI-powered infrastructure for organisations operating complex software environments across sectors, including aviation, finance, cybersecurity and government.

The company’s platform generates software using a customer’s existing design systems, component libraries, technical documentation and internal rules, enabling applications to be built in line with current architectures and engineering standards. The approach is intended to reduce the manual translation between design and engineering teams, a process that often creates delays and inconsistencies in large organisations.

While general-purpose AI coding tools have made it easier to create prototypes and simple applications, many organisations continue to face challenges integrating AI-generated software into production environments that require reliability, compliance and security. DesignVerse says its platform was built specifically for enterprise and mission-critical environments, where software must integrate safely with existing infrastructure.

Andrei Manolache, CEO of DesignVerse, said large organisations still spend significant time translating product design into production-ready software, often leading to inefficiencies between teams.

DesignVerse removes that friction by allowing teams to generate functional enterprise applications directly from their design systems, validate behaviour earlier with stakeholders, and streamline the transition from design to production.

The new funding will be used to expand DesignVerse’s engineering team and accelerate growth across enterprise markets in Europe and the United States.

This week, Nordic Compass launches, a new pan-Nordic industry alliance for resilience and competitiveness. 
The ambition is to move faster than the current European process and turn Nordic industrial strengths into concrete initiatives, aligned between the business community and the Nordic governments. 

Initiatives in four critical areas will be presented at the Nordic Compass Summit in Gothenburg on 4-5 November. At the first summit this autumn, the alliance will launch concrete initiatives aimed at the Nordic capital markets, deep tech, defence, and energy that can be implemented and scaled up quickly.

Nordic Compass is chaired by former Prime Minister of Finland, Jyrki Katainen.

The ambition is to strengthen Nordic and European resilience and competitiveness amid rising geopolitical tensions.

The Nordic countries are individually small but are regarded among the best in capacity for innovation. Taken together, the Nordic Region ranks among the world's largest economies, yet industrial cooperation across the region remains underutilised, according to the alliance.

Nordic Compass gathers more than 25 leading Nordic companies, foundations and organisations as partners in various capacities, including Aker ASA, Aker Solutions, Alfa Laval, atNorth, Carl Bennet AB, Chr. Augustinus Fabrikker, Danfoss, Embla Medical, EQT, Ericsson, EY, The Finnish Innovation Fund Sitra, KONE, Kromann Reumert, McKinsey & Company, Nasdaq Nordic, Nokia, Nordea, Nordic Innovation, Novo Nordisk Foundation, Nscale, Saab, SEB, Vattenfall, Wallenberg Investments, and Ørsted.

An advisory board to Nordic Compass will provide national insights through eight representatives from the Nordic countries, including Greenland, the Faroe Islands and Åland, as well as the Secretary General of the Nordic Council of Ministers.

Lead image: Markus Esselmark.

Healthtech startup Corti today announced the launch of the Startup Acceleration Program, a no-equity initiative providing healthcare AI builders worldwide with access to the same clinical-grade models that power AI for highly regulated systems across Europe and the US. The grant-funded program aims to help founders ship and scale at a moment when the regulatory bar for healthcare AI has never been higher.

Check out our earlier interview with Andreas Cleve, CEO and co-founder of Corti.

Copenhagen-headquartered Corti offers healthcare a frontier lab for clinical-grade AI. Symphony, its flagship clinical-grade AI model, powers clinical and administrative applications for EHR vendors, virtual care platforms, practice management systems, and life sciences organisations worldwide. It serves over 100 million patients annually across health systems, including the NHS. 

Symphony has outscored OpenAI on HealthBench Professional, the company’s new healthcare benchmark. Healthcare AI builders now face tightening regulation in every major market - from the FDA's expanded AI/ML guidance in the US to new lifecycle accountability requirements in Canada and the UK.

But Europe is the most acute case. In the past four weeks, OpenAI rolled out free clinical AI  to every verified American physician. One week later, OpenEvidence — a clinical AI platform used daily by 40 per cent of US physicians and valued at $12 billion — withdrew from the UK and European markets, citing regulatory uncertainty around the EU AI Act. 

The high-risk system requirements that drove that decision will come into force for medical AI on August 2, 2026. Europe has emerged as the toughest proving ground for clinical-grade AI - and the asymmetry is sharpening. EU MDR certification alone now costs founders between €200,000 and €600,000 per device and takes 12 to 18 months.

Capital is concentrating in larger, later-stage rounds, with investors increasingly favouring companies with proven clinical evidence and workflow integration.

The structural difficulty is real enough to deter horizontal players - and the vertical products built on them - from competing in Europe, implying a narrower path for the next wave of healthcare AI builders to succeed there at exactly the moment they are needed most. But the reality is that the conditions making Europe hard for horizontal players are the same conditions that Corti was built for:

"The future of healthcare AI won't be built by one company. It will be built by thousands of teams, each with deep knowledge of a specific care setting, workflow, or patient population," said Andreas Cleve, co-founder and CEO of Corti.  

"Our job is to give those builders a head start: the leading clinical AI model, the evidence base behind it, and a path to production we've already navigated for regulated health systems. So they can focus on what only they can do - the workflow, the patient population, the problem they actually understand."

Among the hundreds of development teams already building on Corti is Aisel Health, a European startup building AI for psychiatry.

Check out our earlier interview with Augusta Klingsten Peytz, co-founder of Aisel.

According to  Augusta Klingsten Peytz, co-founder and CEO of Aisel Health, Psychiatrists are a scarce and highly specialised resource. 

“They should be focused on one thing only: making clinical decisions - everything else needs to go. Yet today, the majority of a psychiatrist’s time is spent not on clinical decision-making, but on the administrative and repetitive workflows surrounding it.

By using Corti, we at Aisel can focus on delivering specialised psychiatric workflows that help clinicians regain capacity, rather than rebuilding the clinical-grade foundation underneath.”

The Startup Acceleration Program includes:

• Up to $5,000 in credits across the full Symphony stack - Agents, Medical Coding, Speech-to-Text, and Text Generation - built on over 1.5 million hours of clinical audio.
• Support from Corti's clinical and regulatory team to navigate EU AI Act, MDR, and data residency requirements.
• Dedicated time with Corti's AI experts to scope product roadmaps and architect the right system before code is written.
• Founder-led webinars on industry developments and Corti's own roadmap.
• Invitations to Corti events in New York, Copenhagen, London, and Berlin

Applications open today, reviewed on a rolling basis with a one-week turnaround. No pitching, no committee, no equity. Open to worldwide pre-seed through Series B companies building in healthcare, clinical workflows, or adjacent life sciences.

BioInnovation Institute (BII) is launching AI Lab, a new innovation platform designed to support the commercialisation of artificial intelligence research and accelerate the development of early-stage AI startups in Denmark. The initiative is backed by € 7 million (DKK 60 million) in funding from the Danish Industry Foundation and aims to strengthen collaboration between startups, researchers and industrial companies while helping bring AI-based technologies to market more quickly.

AI Lab will be operated by BII, which, since 2018, has supported more than 140 startups across life sciences, quantum technology and biosolutions with funding, infrastructure and commercialisation support. Through the AI Lab, BII will expand its activities into artificial intelligence, focusing on helping startups develop scalable AI solutions and attract external investment.

The programme will provide selected startups with non-dilutive financial support, access to datasets from Danish companies and institutions, computing infrastructure, technical guidance and connections to potential customers through BII’s industry network. AI Lab will also include an AI-focused accelerator programme designed to help startups become investment-ready and launch pilot projects more quickly.

According to BII, the initiative is intended to address the gap between Denmark’s strong digital infrastructure and the slower adoption and commercialisation of AI technologies within the Danish industry.

Jens Nielsen, CEO of BII, said Denmark has strong foundations for AI development due to its digital infrastructure, publicly available data, research environments and industrial base.

With AI Lab, we at BII aim to create a hub where the right stakeholders can meet and collaborate to turn advanced AI into solutions that make a tangible difference in industry.
The goal is quite simply to shorten the path from a good idea in an academic environment to implementation in the market. At BII, we have proven that we are good at this in other areas, and we hope the same will be true for AI.

Thomas Hofman Bang, CEO of the Danish Industry Foundation, said AI is increasingly becoming a core part of how companies operate and compete, making stronger collaboration between academia, startups and industry increasingly important.

The new platform forms part of BII’s broader efforts to support science-based innovation and help research-driven startups scale commercially across Denmark and internationally.

Sir Demis Hassabis has hailed a multi-billion-dollar investment in the startup he founded which was spun out of Google DeepMind and focuses on leveraging AI to help drug discovery as a “massive vote of confidence”. 

Isomorphic Labs said it has raised $2.1bn in a Series B funding. The funding round was led by existing investor Thrive Capital, the US VC, with participation from existing backers Alphabet, Isomorphic's parent company, and its venture captial unit, GV.  

New investors include Singapore's Temasek, Google’s growth fund arm CapitalG, and the UK Sovereign AI Fund.

Hassabis, CEO and founder of Isomorphic Labs, who also heads up Google’s AI offering, said: “This funding round is a massive vote of confidence from a diverse group of top-tier international investors in our AI-first approach to drug design and development.

"Now that we have shown our approach is fundamentally sound, our focus is on scaling our technology to its full potential. This capital injection allows us to build out our drug design engine at scale, driving us forward in our mission to solve all disease."

Isomorphic Labs is built on software that DeepMind developed, including its Nobel Prize-winning AlphaFold, which predicts protein structures.

Isomorphic Labs is researching treatments for cancer and immune disorders.

Isomorphic Labs said the new funds will be geared towards the development and deployment of Isomorphic Labs' AI drug design engine (IsoDDE), with the aim of speeding up and expanding its pipeline of therapeutic programmes.

The funding would also be used to recruit top-tier AI, engineering, drug design, and clinical talent, it said. Isomorphic Labs raised $600m in May last year, marking its first external funding round.

  Tomoro was created in 2023 in alliance with OpenAI. The Edinburgh and London-based firm built AI concierges for Virgin Atlantic, in-game support agents for Supercell, and deployment systems for Fidelity International, Tesco, Red Bull, Mattel, and the NBA. It grew monthly revenue tenfold in 12 months. It pledged 10 million pounds to Scottish AI […]